Formulation and transdermal delivery of aciclovir and ketoconazole for HIV/AIDS patients

Abstract

Due to their compromised immune systems, HIV/ AIDS- infected individuals are more susceptible to skin infections. Since fungal and viral cutaneous manifestations are frequently encountered in combination in HIV/AIDS patients, it is appropriate to formulate a topical product containing both ketoconazole (antifungal) and aciclovir (antiviral)